Forte Biosciences has acquired 1 company, including 1 in the last 5 years.
Forte Biosciences has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
1124 West Carson Street MRL Building 3-320,
Torrance, California
90502
United States,
(310) 618-6994
www.fortebiorx.com
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2020-06-15 |
Tocagen · Life Science
San Diego, California · www.tocagen.com Tocagen is a fully integrated global biotech company that develops first-in-class, broadly applicable, product candidates, that are designed to activate a patient’s immune system against their own cancer from within. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. Tocagen was formed in 2007 and is based in San Diego, California. Advisors: Cooley , Ladenburg Thalmann & Co. |
- | Merger | - |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
